TROV Insider Trading Activity and SEC Form 4 Filings
TROV insider trading summary
No open-market insider purchases or sales of Trovagene, Inc. (TROV) have been reported on SEC Form 4 in the past 12 months.
Latest TROV insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 20, 2018 | Rodney S Markin | Director | Buy | $35K (41,200 @ $0.85) |
| Jun 8, 2018 | Stanley Tennant | Director | Buy | $8K (10,000 @ $0.80) |
| Jun 8, 2018 | John P Brancaccio | Director | Buy | $8K (10,000 @ $0.80) |
| Sep 5, 2017 | Stanley Tennant | Director | Sell | $6K (8,334 @ $0.69) |
| Dec 19, 2016 | Stanley Tennant | Director | Buy | $21K (10,000 @ $2.10) |
| Dec 16, 2016 | William J Welch | CEO | Buy | $5K (2,250 @ $2.09) |
| Dec 16, 2016 | Stanley Tennant | Director | Buy | $30K (14,966 @ $2.00) |
| Dec 16, 2016 | William J Welch | CEO | Buy | $5K (2,500 @ $2.10) |
| Dec 14, 2016 | Mark Erlander | Chief Scientific Officer | Buy | $10K (5,000 @ $2.08) |
| Nov 11, 2016 | Bridger Management, LLC | Insider | Buy | $993K (322,472 @ $3.08) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.